Factors Influencing Choice of Rituximab Versus an Alternative Tumor Necrosis Factor Inhibitor Following Tumor Necrosis Factor Inhibitor Failure in Patients with Rheumatoid Arthritis: Sub-Analysis of a Global, Observational Comparative Effectiveness Study.

被引：0

作者：

Finckh, Axel ^{[1
]}

Gottenberg, Jacques-Eric ^{[2
]}

Mpofu, Chiedzo ^{[3
]}

Bensen, William G. ^{[4
,5
]}

Rubbert-Roth, Andrea ^{[6
]}

Irazoque, Fedra ^{[7
]}

Martinez Taboada, Victor ^{[8
]}

Chung, Carol ^{[9
]}

Hinsch-Gylvin, Lykke ^{[3
]}

Ferri, Clodoveo ^{[10
]}

Emery, Paul ^{[11
]}

机构：

[1] Univ Hosp Geneva, Geneva, Switzerland

[2] CHU Strasbourg, F-67000 Strasbourg, France

[3] F Hoffmann La Roche & Co Ltd, CH-4002 Basel, Switzerland

[4] McMaster Univ, Hamilton, ON, Canada

[5] St Josephs Hosp, Hamilton, ON, Canada

[6] Univ Cologne, D-50931 Cologne, Germany

[7] Hosp Angeles Mocel, Mexico City, DF, Mexico

[8] Hosp Univ Marques de Valdecilla, Santander, Spain

[9] Genentech Inc, San Francisco, CA 94080 USA

[10] Univ Modena & Reggio Emilia, Modena, Italy

[11] Univ Leeds, Leeds, W Yorkshire, England

来源：

ARTHRITIS AND RHEUMATISM | 2012年 / 64卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

456

引用

页码：S198 / S198

页数：1